This past week four IPOs debuted, eleven updated terms and two new deals filed. It was tough sledding for the four deals that debuted. The strongest deal of the week, BluePrint Medicines Corporation (Nasdaq: BPMC), upsized and priced ($18.00) above range. ‘BPMC’ opened 30-percent higher with a $23.40 tick at first trade. However, BluePrint traded[…]